Patent · US Active

Methods of cleaving DNA with rationally-designed meganucleases

US8143016B2 · kind B2 · utility

10Cited by
20References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2011
Grant dateMar 27, 2012
Priority date
Expiry dateSep 27, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Rationally-designed LAGLIDADG meganucleases and methods of making such meganucleases are provided. In addition, methods are provided for using the meganucleases to generate recombinant cells and organisms having a desired DNA sequence inserted into a limited number of loci within the genome, as well as methods of gene therapy, for treatment of pathogenic infections, and for in vitro applications in diagnostics and research.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.